Dr Reddys Laboratories (RDY) Consolidated Net Income (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Consolidated Net Income of $95.56 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 41.6% from $163.58 million a year earlier but up 108.1% from the prior quarter.
Dr Reddys Laboratories (RDY) Consolidated Net Income (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Consolidated Net Income came in at $299.19 million as of Sep 30, 2026, down 55.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $452 million, down 32.6% from FY2025.
- Annual Consolidated Net Income has a five-year compound annual growth rate of 13.9% (FY2021 to FY2026).
- Across earlier fiscal years, Consolidated Net Income came in at $671 million in FY2025 (+0.4%), $668 million in FY2024 (+21.9%), $548 million in FY2023 (+76.2%) and $311 million in FY2022 (+31.8%).
- Quarterly Consolidated Net Income has ranged from $11.64 million in fiscal Q4 2022 to $183.29 million in fiscal Q4 2025 over the past five years.
- On a year-over-year basis, Consolidated Net Income has declined for four consecutive quarters, with an average decline of 25.3% over the last eight quarters.
- Peak year-over-year performance for Consolidated Net Income in the last five years was growth of 143.8% in fiscal Q3 2023, against a decline of 86.8% in fiscal Q4 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $45.93 million (Q1 2027), $24.12 million (Q4 2026) and $133.59 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 95.56 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 95.56 Mn |
| Jun 30, 2026 | 45.93 Mn |
| Mar 31, 2026 | 24.12 Mn |
| Dec 31, 2025 | 133.59 Mn |
| Sep 30, 2025 | 163.58 Mn |
| Jun 30, 2025 | 164.71 Mn |
| Mar 31, 2025 | 183.29 Mn |
| Dec 31, 2024 | 166.26 Mn |
| Sep 30, 2024 | 160.17 Mn |
| Jun 30, 2024 | 166.87 Mn |
| Mar 31, 2024 | 157.38 Mn |
| Dec 31, 2023 | 165.60 Mn |
| Sep 30, 2023 | 179.04 Mn |
| Jun 30, 2023 | 178.00 Mn |
| Mar 31, 2023 | 169.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 152.00 Mn |
| Jun 30, 2022 | 135.00 Mn |
| Mar 31, 2022 | 11.64 Mn |
| Dec 31, 2021 | 48.00 Mn |
Dr Reddys Laboratories Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();